跳至主要内容
临床试验/NCT01468038
NCT01468038已完成3 期

Sentra PM (a Medical Food) and Trazadone in the Management of Sleep Disorders

Targeted Medical Pharma1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
111
试验地点
1
主要终点
Time to fall asleep

研究概览

简要总结

This is a double blind placebo controlled study of one hundred and four subjects which will be randomized for treatment with Sentra PM alone, Sentra PM with trazadone, trazadone alone and placebo alone. Twenty -six subjects will be randomly placed in one of the four groups. Each of the one hundred and four subjects will undergo baseline examination to include a sleep study questionnaires and 24- hour electrocardiographic recording. The one hundred and four subjects will then be randomly placed in one of the four groups.

详细描述

Sentra PM can induce restorative sleep compared to placebo, and as good as a sleep drug (trazadone) in subjects experiencing non-restorative sleep. Sentra PM taken with trazadone works better than either product alone. Twenty-six subjects will be randomized to a two week ingestion of Sentra PM at bedtime, twenty-six subjects will be randomized to a two week ingestion of trazadone at bedtime, twenty-six subjects will be randomized to a two week ingestion of Sentra PM with trazadone at bedtime and twenty -six subjects will be randomized to a two week ingestion of placebo at bedtime. Each morning after ingestion of either active product or placebo, the subject will fill out sleep questionnaires. On the fourteenth day of ingestion, a repeat 24-Hour ECG examination will be performed on all one hundred and four subjects and each subject will give a second blood sample for analysis. On the morning of the 14th day of ingestion the final sleep questionnaires will be completed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females over the age of 18 and below age
  • Patients with a history of a sleep disturbance with non-restorative sleep defined by perceived increase in sleep latency or morning/daytime grogginess.

排除标准

  • Subjects who have previously taken GABAdone, SentraPM or trazadone.
  • Subjects who are currently taking tricyclic anti-depressants.
  • Any blood chemistry anomalies the investigator finds that may put the patient at risk or invalidate study results.
  • Pregnant or lactating females.
  • Subjects with implanted pacemakers or other implanted electrical devices

研究组 & 干预措施

Sentra PM and trazodone

Active Comparator

Active Sentra PM and active trazodone

干预措施: Sentra PM and Trazodone (CoPack Kit Trazamine) (Drug)

Active trazodone and placebo

Active Comparator

trazodone 50mg with Sentra PM-like placebo

干预措施: Trazodone (Drug)

placebo and active Sentra PM

Active Comparator

Trazodone-like placebo and Sentra PM

干预措施: Sentra PM (Other)

placebo trazodone and placebo Sentra PM

Placebo Comparator

trazadone-like placebo and Sentra PM-like placebo

干预措施: Placebo trazodone and placebo Sentra PM (Drug)

结局指标

主要结局

Time to fall asleep

时间窗: 14 days

Subjects time to fall asleep will be measure by patient response to questionnaires to determine if time improved, stayed the same or worsen.

次要结局

  • Quality of Sleep(14 days)
  • Morning grogginess(14 days)
  • Feelings of depression(14 days)
  • Feelings of anxiety(14 days)
  • Improvement in parasympathetic activity(14 days)

研究者

发起方
Targeted Medical Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验